AtonRa Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,565
Closed -$222K 123
2023
Q1
$222K Sell
8,565
-1,205
-12% -$32.2K 0.32% 117
2022
Q4
$231K Sell
9,770
-1,955
-17% -$52.7K 0.29% 106
2022
Q3
$297K Sell
11,725
-3,343
-22% -$117K 0.29% 110
2022
Q2
$500K Buy
15,068
+3,192
+27% +$136K 0.46% 100
2022
Q1
$857K Sell
11,876
-1,985
-14% -$143K 0.47% 83
2021
Q4
$1.27M Sell
13,861
-3,884
-22% -$464K 0.44% 82
2021
Q3
$2.25M Buy
17,745
+1,691
+11% +$246K 0.75% 57
2021
Q2
$2.67M Buy
16,054
+449
+3% +$72.8K 0.98% 46
2021
Q1
$2.84M Sell
15,605
-2,762
-15% -$641K 1.26% 26
2020
Q4
$3.67M Buy
+18,367
New +$3.73M 1.8% 9

Other funds holding TDOC

AtonRa Partners's TDOC Position: Q2 2023 in Review

AtonRa Partners sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 8,565 shares — an estimated $222K sold.

AtonRa Partners first reported a position in TDOC in Q4 2020 and held it in 10 quarters. The position peaked at $3.67M in Q4 2020. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • AtonRa Partners reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • AtonRa Partners sold 8,565 Teladoc Health shares in Q2 2023, an estimated $222K.
  • AtonRa Partners first reported a position in Teladoc Health in Q4 2020 and held it in 10 quarters.
  • AtonRa Partners's Teladoc Health position peaked at $3.67M in Q4 2020.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on AtonRa Partners's 13F filing for Q2 2023, filed 18 Jul 2023.